Current Drug Targets
Volume 22, 17 Issues, 2021
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Drug Targets, Volume 22 - Number 1
Biography Open Access
Editorial Open Access
Review Article
How can we Preserve Sexual Function after Ablative Surgery for Benign Prostatic Hyperplasia?
, 22(1): 4 - 13Ioannis Mykoniatis*, Koenraad Van Renterghem and Ioannis Sokolakis
DOI: 10.2174/1389450121666200925143916
How can we Preserve Sexual Function after Ablative Surgery for Benign Prostatic Hyperplasia?
Review Article
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?
, 22(1): 14 - 21Beppe Calò*, Michele Marchionni, Francesca Sangusedolce, Ugo Giovanni Falagario, Marco Chirico, Giuseppe Carrieri and Luigi Cormio
DOI: 10.2174/1389450121666200802022150
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere?
Review Article
Phytotherapy and Herbal Medicines for Kidney Stones
, 22(1): 22 - 30Esteban Emiliani*, Adrian Jara and Andres Koey Kanashiro
DOI: 10.2174/1389450121666200929115555
Phytotherapy and Herbal Medicines for Kidney Stones
Systematic Review Article
Phosphodiesterases 5 Inhibitors and Erectile Dysfunction Recovery after Pelvic Surgery: Future Perspectives for New Drugs and New Formulations
, 22(1): 31 - 37Riccardo Lombardo, Giorgia Tema and Cosimo De Nunzio*
DOI: 10.2174/1389450121666200925145347
Phosphodiesterases 5 Inhibitors and Erectile Dysfunction Recovery after Pelvic Surgery: Future Perspectives for New Drugs and New Formulations
Review Article (Mini-Review)
Computational and Biological Investigations on Abl1 Tyrosine Kinase: A Review
, 22(1): 38 - 51Masilamani Elizabeth Sobhia*, G. Siva Kumar, Antara Mallick, Harmanpreet Singh, Kranthi Kumar, Meenakshi Chaurasiya, Narendra Gera, Sindhuja Deverakonda and Vinay Baghel
DOI: 10.2174/1389450121999201013152513
Computational and Biological Investigations on Abl1 Tyrosine Kinase: A Review
Review Article (Mini-Review)
COVID-19 and Renal Diseases: An Update
, 22(1): 52 - 67Letícia Bitencourt Cota, Ana Luisa Pedrosa, Stephanie Bruna Camilo Soares de Brito, Ana Cláudia Fontoura Fróes, Sarah Tayná de Carvalho, Giulio Gori Fonseca, Guilherme Costa Ferreira, Pollyanna Faria Fradico and Ana Cristina Simões e Silva*
DOI: 10.2174/1389450121999201013151300
COVID-19 and Renal Diseases: An Update
General Review Article
Neoadjuvant Strategies Before Radical Prostatectomy for High Risk Prostate Cancer in the Era of New Hormonal Agents
, 22(1): 68 - 76Alessandro Tafuri, Maria Angela Cerruto and Alessandro Antonelli*
DOI: 10.2174/1389450121666200621194409
Neoadjuvant Strategies Before Radical Prostatectomy for High Risk Prostate Cancer in the Era of New Hormonal Agents
General Review Article
Molecular Signaling Pathways and Essential Metabolic Elements in Bone Remodeling: An Implication of Therapeutic Targets for Bone Diseases
, 22(1): 77 - 104Aditi Sharma, Lalit Sharma and Rohit Goyal*
DOI: 10.2174/1389450121666200910160404
Molecular Signaling Pathways and Essential Metabolic Elements in Bone Remodeling: An Implication of Therapeutic Targets for Bone Diseases
General Review Article
Progress on the Mechanism for Aspirin’s Anti-tumor Effects
, 22(1): 105 - 111Lin Zheng, Weibiao Lv*, Yuanqing Zhou, Xu Lin and Jie Yao*
DOI: 10.2174/1389450121999201013152931
Progress on the Mechanism for Aspirin’s Anti-tumor Effects
General Review Article
Robotic Surgery in Inflammatory Bowel Disease
, 22(1): 112 - 116Jacopo Crippa, Michele Carvello, Paulo Gustavo Kotze and Antonino Spinelli*
DOI: 10.2174/1389450121999200820125918
Robotic Surgery in Inflammatory Bowel Disease
General Review Article
‘Treat to Target’ in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
, 22(1): 117 - 125Arianna Dal Buono, Giulia Roda, Marjorie Argollo, Kristine Paridaens, Laurent PeyrinBiroulet and Silvio Danese*
DOI: 10.2174/1389450121666200727120305
‘Treat to Target’ in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy
General Review Article
Thrombosis in IBD in the Era of JAK Inhibition
, 22(1): 126 - 136Virginia Solitano, Gionata Fiorino, Ferdinando D’Amico, Laurent Peyrin-Biroulet and Silvio Danese*
DOI: 10.2174/1389450121666200902164240
Thrombosis in IBD in the Era of JAK Inhibition
General Review Article
Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
, 22(1): 137 - 145Tomasz Mackiewicz, Aleksander Sowa and Jakub Fichna*
DOI: 10.2174/1389450121666200220123844
Biomarkers for Early Detection of Colitis-associated Colorectal Cancer - Current Concepts, Future Trends
Editor-in-Chief
Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63
Webmaster Contact: info@benthamscience.net